Results 171 to 180 of about 2,034,426 (313)
We present the case of a 55‐year‐old male who experienced a cryptogenic ischemic stroke, likely due to a patent foramen ovale (PFO) in the setting of an incomplete cor triatriatum sinister (CTS) and a 30 mm GORE Cardioform Septal Occluder was successfully implanted.
Anastasios Apostolos +8 more
wiley +1 more source
Tricuspid regurgitation in the era of transcatheter intervention: beyond multivalvular complexity towards haemodynamic phenotyping. [PDF]
Donal E +3 more
europepmc +1 more source
The clinical manifestations of PFO. Although the majority of PFOs are benign and asymptomatic, they can present with a variety of clinical manifestations, or coexisting with other diseases and aggravating their symptoms, including cerebral diseases (such as CS, epilepsy, TIA, or migraine), systemic embolism (such as embolism in renal artery, coronary ...
Linlin Meng +6 more
wiley +1 more source
Transcatheter Intervention for Multiple Valve Diseases in a Patient With Cardiogenic Shock. [PDF]
Hu S +6 more
europepmc +1 more source
Routine Versus Deferred Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis With Reconstructed Individual Patient Data [PDF]
Mahmoud Balata +12 more
openalex +1 more source
Background: Treatment of residual mitral regurgitation (MR) with different percutaneous devices after transcatheter edge-to-edge repair (TEER) has been reported as an alternative option to reclipping or surgery.
Baudo M. +12 more
core +1 more source
Intraprocedural Transesophageal Echocardiography Ensures Accurate Anchoring During Transcatheter Intervention for Aortic Regurgitation. [PDF]
Fan KW +6 more
europepmc +1 more source
ABSTRACT Aim To evaluate the implementation effectiveness of a multicomponent multidisciplinary Enhanced Recovery After Surgery pathway integrated with an information platform for patients undergoing transcatheter aortic valve implantation. Design A single‐center quasi‐experimental study with a non‐concurrent historical control group.
Shaoping Lin +6 more
wiley +1 more source

